F-star Therapeutics Appoints James Sandy as Chief Development Officer
Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer| (NASDAQ: FSTX) | Delayed: 7.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.12 | 52 Week High | $ | |||
| Open | $12.36 | 52 Week Low | $ | |||
| Day High | $7.12 | P/E | N/A | |||
| Day Low | $7.12 | EPS | $ | |||
| Volume | 1,067,673 | |||||
| (NASDAQ: IMCR) | Delayed: 31.83 +0.55 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.28 | 52 Week High | $ | |||
| Open | $31.22 | 52 Week Low | $ | |||
| Day High | $31.93 | P/E | N/A | |||
| Day Low | $31.04 | EPS | $ | |||
| Volume | 160,572 | |||||



